Physical Activity in Elderly Kidney Transplant Patients with Multiple Renal Arteries

Calogero, Armando; Sagnelli, Caterina; Peluso, G.; Sica, Antonello; Cândida, Maria; Campanile, Silvia; Minieri, Gianluca; Incollingo, Paola; Creta, Massimiliano; Pelosio, Luigi; Tammaro, Vincenzo; Scotti, Alessandro; Jamshidi, Akbar; Caggiano, Marcello; Sagnelli, Evangelista; Dodaro, Concetta Anna; Carlomagno, Nicola; Santangelo, Michele

doi:10.20944/preprints201912.0380.v1

Cited by 4 publications

(3 citation statements)

References 46 publications

(46 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Renal transplantation (RT) from living donors provides significant advantages compared to transplantation from deceased donors including improved long-term survival, immediate functioning of the transplant, better transplant survival, and the possibility of transplanting preemptively [ 1 – 5 ]. An ideal kidney donor has no renal disease, no active infection, and no transmissible malignancy.…”

Section: Introductionmentioning

confidence: 99%

[Retracted] Outcomes of Renal Stone Surgery Performed Either as Predonation or Ex Vivo Bench Procedure in Renal Grafts from Living Donors: A Systematic Review

Longo

Calogero

Creta

et al. 2020

BioMed Research International

Self Cite

View full text Add to dashboard Cite

Aims. We aimed to summarize available evidence about intraoperative and postoperative donors’ and recipients’ outcomes following stone surgery in renal grafts from living donors performed either before donation or as ex vivo bench surgery at the time of living-donor nephrectomy. Methods. A systematic review of PubMed, ISI Web of Knowledge, and Scopus databases was performed in September 2020. We included full papers that met the following criteria: original research, English language, human studies, and describing the results of stone surgery in renal grafts from living donors performed either before transplantation or as ex vivo bench surgery. Results. We identified 11 studies involving 106 patients aged between 22 and 72 years. Predonation and bench stone surgery was performed in 9 (8.5%) and 96 (90.6%) patients, respectively. Predonation stone surgery involved extracorporeal shock wave lithotripsy, retrograde intrarenal surgery, and percutaneous nephrolithotomy in 8, 1, and 1 patient, respectively. The overall success rate of predonation stone surgery was 78%, and the complication rate was 0%. Bench stone surgery involved ureteroscopy, pyelolithotomy, or a combination of both in 79 (82.3%), 10 (10.4%), and 7 (7.3%) cases, respectively, with an overall success rate of 95.8% and an overall complication rate of 9.37%. Conclusions. Predonation and bench stone surgery in grafts from living donors represents efficacious and safe procedures. Further studies on wider series with a longer follow-up are required.

show abstract

Section: Introductionmentioning

confidence: 99%

[Retracted] Outcomes of Renal Stone Surgery Performed Either as Predonation or Ex Vivo Bench Procedure in Renal Grafts from Living Donors: A Systematic Review

Longo

Calogero

Creta

et al. 2020

BioMed Research International

Self Cite

View full text Add to dashboard Cite

show abstract

“…[6][7][8][9][10][11][12] These considerations also apply to the context of bone marrow transplantation. [13][14][15] We have prepared this review article for all doctors who have not had the opportunity to investigate the different aspects of COVID-19 sufficiently, including young infectious disease specialists, hematologists, and general practitioners, who for more than one reason may meet patients with COVID-19, having to make a first diagnosis and the first decisions about it.…”

mentioning

confidence: 99%

The impact of the SARS‐CoV‐2 infection, with special reference to the hematological setting

Sica

Casale

Rossi

et al. 2020

Journal of Medical Virology

Self Cite

View full text Add to dashboard Cite

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a disease known from a few months, caused by a recently arisen virus and, consequently, it is little known. The disease has a benign course in most infected subjects (children and young adults), is often symptomatic in adults over the age of 50 and often serious and life threatening in people with comorbidities and the elderly. The few data published on coronavirus disease-2019 (COVID-19) in the blood-oncology field report a serious clinical presentation, a serious course of the disease, and a high mortality rate, as has also been reported for other cancer contexts. The current strategy for treating patients with SARS-CoV-2 includes antivirals that are effective against other viral infections and drugs that can moderate the cytokine storm. There is no specific vaccine and consequently all possible precautions must be taken to prevent SARS-CoV-2 infection in the areas of oncology, oncohematology, and bone marrow transplantation. In this reviewer's article, we report the information currently available on SARS-CoV-2 infection to help young doctors and hematologists to successfully manage patients with COVID-19.

show abstract

“…Kidney disease developed during SARS-CoV-2 infection is associated with an increased risk of mortality [41,42] and patients in the end-stage renal disease (ESRD) are at an increased risk for severe COVID-19. European centers report a mortality rate of 20-30% in COVID-19 patients undergoing chronic dialysis [46][47][48][49][50][51][52][53][54][55], mostly related to the direct SARS-CoV-2 invasion of kidneys followed by a strong cytokine storm, acute respiratory distress syndrome and hypovolemia. Similar rates are reported from same centers in the USA [56,57].…”

Section: Renal Involvement In Sars-cov-2 Infectionmentioning

confidence: 99%

Renal involvement in COVID-19: focus on kidney transplant sector

et al. 2021

Self Cite

View full text Add to dashboard Cite

Introduction Kidney transplant recipients and patients on the waiting list for kidney transplant who acquire SARS-CoV-2 infection are at serious risk of developing severe COVID-19, with an increased risk of mortality for the their immunosuppressive state; other risk factors for mortality have been identified in some comorbidities such as obesity, diabetes, asthma and chronic lung disease. Materials and Methods The COVID-19 pandemic has led to a sharp reduction in kidney transplants in most countries, mainly due to the concern of patients on the waiting list for their potential increased susceptibility to acquire SARS-CoV-2 infection in healthcare facilities and for the difficulties of transplant centers to ensure full activity as hospitals have had to focus most of their attention on COVID-19 patients. Indeed, while the infection curve continued its exponential rise, there was a vertical decline in kidney donation/transplant activity. Conclusion This review article focuses on the damage induced by SARS-CoV-2 infection on kidney and on the adverse effect of this pandemic on the entire kidney transplant sector.

show abstract

Physical Activity in Elderly Kidney Transplant Patients with Multiple Renal Arteries

Cited by 4 publications

References 46 publications

[Retracted] Outcomes of Renal Stone Surgery Performed Either as Predonation or Ex Vivo Bench Procedure in Renal Grafts from Living Donors: A Systematic Review

[Retracted] Outcomes of Renal Stone Surgery Performed Either as Predonation or Ex Vivo Bench Procedure in Renal Grafts from Living Donors: A Systematic Review

The impact of the SARS‐CoV‐2 infection, with special reference to the hematological setting

Renal involvement in COVID-19: focus on kidney transplant sector

Contact Info

Product

Resources

About